𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fibroindex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C

✍ Scribed by Masahiko Koda; Yoshiko Matunaga; Manri Kawakami; Yukihiro Kishimoto; Takeaki Suou; Yoshikazu Murawaki

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
464 KB
Volume
45
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prediction of significant fibrosis in HB
Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model
✍ Min-De Zeng; Lun-Gen Lu; Yi-Min Mao; De-Kai Qiu; Ji-Qiang Li; Mo-Bin Wan; Cheng- πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 2 views

A model was constructed consisting of clinical and serum variables to discriminate between hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) patients with and without significant fibrosis (stages 2-4 vs. stages 0-1). Consecutive treatment-naive CHB patients who underwent liver biopsy

Improved prediction of fibrosis in chron
Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index
✍ Archana Sud; Jason M. Hui; Geoffrey C. Farrell; Priyanka Bandara; James G. Kench πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 134 KB πŸ‘ 1 views

We sought to develop a clinically useful index comprising standard and physiologically relevant variables to predict the probability of significant hepatic fibrosis in subjects with chronic hepatitis C virus (HCV) infection. Fibrosis was graded as mild (stages F0 or F1) or significant (stages F2-F4)

Development of a simple noninvasive inde
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
✍ Richard K. Sterling; Eduardo Lissen; Nathan Clumeck; Ricard Sola; Mendes Cassia πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 261 KB πŸ‘ 1 views

Liver biopsy remains the gold standard in the assessment of severity of liver disease. Noninvasive tests have gained popularity to predict histology in view of the associated risks of biopsy. However, many models include tests not readily available, and there are limited data from patients with HIV/